200 related articles for article (PubMed ID: 9435220)
1. Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin.
Sheng S; Truong B; Fredrickson D; Wu R; Pardee AB; Sager R
Proc Natl Acad Sci U S A; 1998 Jan; 95(2):499-504. PubMed ID: 9435220
[TBL] [Abstract][Full Text] [Related]
2. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
McGowen R; Biliran H; Sager R; Sheng S
Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
[TBL] [Abstract][Full Text] [Related]
3. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin.
Biliran H; Sheng S
Cancer Res; 2001 Dec; 61(24):8676-82. PubMed ID: 11751384
[TBL] [Abstract][Full Text] [Related]
4. Maspin inhibits cell migration in the absence of protease inhibitory activity.
Bass R; Fernández AM; Ellis V
J Biol Chem; 2002 Dec; 277(49):46845-8. PubMed ID: 12384513
[TBL] [Abstract][Full Text] [Related]
5. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.
Yin S; Lockett J; Meng Y; Biliran H; Blouse GE; Li X; Reddy N; Zhao Z; Lin X; Anagli J; Cher ML; Sheng S
Cancer Res; 2006 Apr; 66(8):4173-81. PubMed ID: 16618739
[TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor maspin does not undergo the stressed to relaxed transition or inhibit trypsin-like serine proteases. Evidence that maspin is not a protease inhibitory serpin.
Pemberton PA; Wong DT; Gibson HL; Kiefer MC; Fitzpatrick PA; Sager R; Barr PJ
J Biol Chem; 1995 Jun; 270(26):15832-7. PubMed ID: 7797587
[TBL] [Abstract][Full Text] [Related]
7. Three-state unfolding and self-association of maspin, a tumor-suppressing serpin.
Liu T; Pemberton PA; Robertson AD
J Biol Chem; 1999 Oct; 274(42):29628-32. PubMed ID: 10514431
[TBL] [Abstract][Full Text] [Related]
8. A role of novel serpin maspin in tumor progression: the divergence revealed through efforts to converge.
Sheng S
J Cell Physiol; 2006 Dec; 209(3):631-5. PubMed ID: 17001674
[TBL] [Abstract][Full Text] [Related]
9. Maspin binds to urokinase-type and tissue-type plasminogen activator through exosite-exosite interactions.
Al-Ayyoubi M; Schwartz BS; Gettins PG
J Biol Chem; 2007 Jul; 282(27):19502-9. PubMed ID: 17510061
[TBL] [Abstract][Full Text] [Related]
10. Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells.
Odero-Marah VA; Khalkhali-Ellis Z; Chunthapong J; Amir S; Seftor RE; Seftor EA; Hendrix MJ
Cancer Biol Ther; 2003; 2(4):398-403. PubMed ID: 14508113
[TBL] [Abstract][Full Text] [Related]
11. MnSOD up-regulates maspin tumor suppressor gene expression in human breast and prostate cancer cells.
Duan H; Zhang HJ; Yang JQ; Oberley LW; Futscher BW; Domann FE
Antioxid Redox Signal; 2003 Oct; 5(5):677-88. PubMed ID: 14580325
[TBL] [Abstract][Full Text] [Related]
12. mMaspin: the mouse homolog of a human tumor suppressor gene inhibits mammary tumor invasion and motility.
Zhang M; Sheng S; Maass N; Sager R
Mol Med; 1997 Jan; 3(1):49-59. PubMed ID: 9132279
[TBL] [Abstract][Full Text] [Related]
13. Expression and regulation of tumor suppressor gene maspin in breast cancer.
Maass N; Nagasaki K; Ziebart M; Mundhenke C; Jonat W
Clin Breast Cancer; 2002 Oct; 3(4):281-7. PubMed ID: 12425757
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen.
Blacque OE; Worrall DM
J Biol Chem; 2002 Mar; 277(13):10783-8. PubMed ID: 11788595
[TBL] [Abstract][Full Text] [Related]
15. Maspin sensitizes breast carcinoma cells to induced apoptosis.
Jiang N; Meng Y; Zhang S; Mensah-Osman E; Sheng S
Oncogene; 2002 Jun; 21(26):4089-98. PubMed ID: 12037665
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation of maspin in normal mammary epithelia and breast cancer cells.
Odero-Marah VA; Khalkhali-Ellis Z; Schneider GB; Seftor EA; Seftor RE; Koland JG; Hendrix MJ
Biochem Biophys Res Commun; 2002 Jul; 295(4):800-5. PubMed ID: 12127964
[TBL] [Abstract][Full Text] [Related]
17. Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis.
Cher ML; Biliran HR; Bhagat S; Meng Y; Che M; Lockett J; Abrams J; Fridman R; Zachareas M; Sheng S
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7847-52. PubMed ID: 12788977
[TBL] [Abstract][Full Text] [Related]
18. Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors.
Beltran A; Parikh S; Liu Y; Cuevas BD; Johnson GL; Futscher BW; Blancafort P
Oncogene; 2007 Apr; 26(19):2791-8. PubMed ID: 17057734
[TBL] [Abstract][Full Text] [Related]
19. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells.
Sheng S; Carey J; Seftor EA; Dias L; Hendrix MJ; Sager R
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11669-74. PubMed ID: 8876194
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia effects: implications for maspin regulation of the uPA/uPAR complex.
Schaefer JS; Zhang M
Cancer Biol Ther; 2005 Sep; 4(9):1033-5. PubMed ID: 16123583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
